Iconic #heartfailure trialist @FaiezZANNAD presents meta-analysis of EMPEROR-Reduced and DAPA-HF trials #CVCT2020 @FaiezZANNAD @drdargaray @lucreciamburgos @ersied727 @CVCTForum @SantosGallegoMD @rachkataria @AlexNowbar @vbluml @KevinShahMD @paomorejon
![Glanz ❇️](https://abs.twimg.com/emoji/v2/72x72/2747.png)
![Glanz ❇️](https://abs.twimg.com/emoji/v2/72x72/2747.png)
![Glanz ❇️](https://abs.twimg.com/emoji/v2/72x72/2747.png)
![Symbol für eine Kollision 💥](https://abs.twimg.com/emoji/v2/72x72/1f4a5.png)
![Symbol für eine Kollision 💥](https://abs.twimg.com/emoji/v2/72x72/1f4a5.png)
![Symbol für eine Kollision 💥](https://abs.twimg.com/emoji/v2/72x72/1f4a5.png)
Conclusion slide by @FaiezZANNAD talk on Meta-analysis of SGLT2I (Dapagliflozin and Empagliflozin) in HFrEF